Imperial College London

Prof. Ed Tate appointed to the Scientific Advisory Board of Samsara Therapeutics

by

Samsara Therapeutics Inc.

Congratulations to Prof. Ed Tate who has been appointed to the Scientific Advisory Board of Samsara Therapeutics Inc.

Prof. Ed Tate has been appointed to the Scientific Advisory Board of Samsara Therapeutics Inc., a discovery-stage biotech with a world-leading screening platform for inducers of autophagy and a growing pipeline of small molecule neurodegeneration and rare disease therapeutics.

Alongside the other SAB members, Ed will help the company advance several series of novel compounds into development for Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and certain rare genetic conditions, with a particular focus on target identification and validation.

More information can be found here.

Reporter

Ravi Singh

Ravi Singh
Department of Chemistry

Click to expand or contract

Contact details

Tel: +44 (0)20 7594 5821
Email: ravi.singh@imperial.ac.uk

Show all stories by this author